These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation? Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208 [TBL] [Abstract][Full Text] [Related]
8. Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease. Flynn A; O'Brien T IDrugs; 2008 Apr; 11(4):283-93. PubMed ID: 18379964 [TBL] [Abstract][Full Text] [Related]
9. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease. Shah PB; Losordo DW Adv Genet; 2005; 54():339-61. PubMed ID: 16096018 [TBL] [Abstract][Full Text] [Related]
10. New aspects in vascular gene therapy. Karvinen H; Ylä-Herttuala S Curr Opin Pharmacol; 2010 Apr; 10(2):208-11. PubMed ID: 20163988 [TBL] [Abstract][Full Text] [Related]